Abstract
The author examines the clinical impact of findings from a key international workshop on acid peptic disorders, “Appropriate acid suppression for the healing of acid-related diseases,” and from an important meeting which summarized results of a cross-Canada study of the symptomatic treatment of dyspepsia due to esophagitis and duodenal ulcer disease.